NUPLAZID (ACADIA Pharmaceuticals Inc)
Welcome to the PulseAid listing for the NUPLAZID drug offered from ACADIA Pharmaceuticals Inc. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | ACADIA Pharmaceuticals Inc |
| NON-PROPRIETARY NAME: | pimavanserin tartrate |
| SUBSTANCE NAME: | PIMAVANSERIN TARTRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Atypical Antipsychotic [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-04-29 |
| END MARKETING DATE: | 0000-00-00 |
NUPLAZID HUMAN PRESCRIPTION DRUG Details:
| Item Description | NUPLAZID from ACADIA Pharmaceuticals Inc |
| LABELER NAME: | ACADIA Pharmaceuticals Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 17(mg/1) |
| START MARKETING DATE: | 2016-04-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63090-170_2b8b1eee-4c53-4eba-a8a5-e432eda06913 |
| PRODUCT NDC: | 63090-170 |
| APPLICATION NUMBER: | NDA207318 |
Other PIMAVANSERIN TARTRATE Pharmaceutical Manufacturers / Labelers:
